MedPage Today on MSN
Novel T-Cell Therapy Promising in Tough-to-Treat Eye Cancer
Among 16 patients with this difficult-to-treat tumor "with few treatment options," the confirmed overall response rate (ORR) ...
Twenty-month-old Vida Rodriguez is the reason her 7-year-old sister, Alessia, is playing at home — instead of lying in a ...
CDR-Life announces early clinical data demonstrating pharmacodynamic activity of CDR404: Zurich, Switzerland Saturday, October 25, 2025, 18:00 Hrs [IST] CDR-Life, Inc, a biotechno ...
Steven Tahmooressi to lead global marketing efforts for GraftAssure family of assays and future productsBrings 25 years of ...
Researchers report the first human test of an enzyme-converted A-type kidney to universal O, which if validated in future ...
A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in ...
Covers low tumor burden “watch-and-wait” setting, an unmet medical needRegistrational Phase 3 watch-and-wait to start in 2026EO2463 has broad ...
Researchers at Cincinnati Children’s Hospital Medical Center, in collaboration with Roche, have developed a next-generation ...
The Manila Times on MSN
Ateneo de Manila University using immunoinformatics used to identify promising targets to advance ulcer vaccine
SCIENTISTS at Ateneo de Manila University are now using powerful computer programs to identify promising targets for a ...
The indolent lymphoma market is witnessing steady growth driven by the increasing prevalence of slow-growing non-Hodgkin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback